Physician Assistant in Malvern, AR Accepting Medicare

6 Physician Assistant nurses found. Showing 1 - 6

Haley Beth Hobson, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1308 E Page Ave, Malvern, AR 72104 Phone: 501-337-9820    Fax: 870-895-2164

Ms. Mendy Beth Corter, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1003 Schneider Dr, Malvern, AR 72104 Phone: 501-337-5678    Fax: 501-332-6759

Sarah Joan Hamilton, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 250 Abby Loop, Malvern, AR 72104 Phone: 501-881-8281

Mrs. Leah Harmon Costello, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1002 Schneider Dr Ste 104, Malvern, AR 72104 Phone: 501-332-7981    Fax: 501-337-9964

Ms. Dara M Mooney, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1003 Schneider Dr, Malvern, AR 72104 Phone: 501-337-5678    Fax: 501-332-6759

Mr. Edward T Costello, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1002 Schneider Dr, Suite 104, Malvern, AR 72104 Phone: 501-332-7981    Fax: 501-337-9964

News Archive

Laureate Pharma and Iconic Therapeutics complete manufacturing hI-con1 recombinant Fc-Factor VII fusion protein

Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and GMP manufacture of monoclonal antibodies, fusion proteins and other therapeutic protein products, and Iconic Therapeutics, a company focused on the development of treatments for wet adult macular degeneration (wet AMD) and other ophthalmic diseases, today announced the completion of the manufacture of the first GMP lot of hI-con1(TM) recombinant Fc-Factor VII fusion protein.

ViroPharma expands securities repurchase program

ViroPharma Incorporated today announced that the company's Board of Directors has authorized the use of up to an additional $200 million to repurchase shares of its common stock and/or its 2% Senior Convertible Notes due 2017.

Playing sport during COVID-19 pandemic eased anxiety and depression for students

School sports came to an abrupt halt during the COVID-19 (coronavirus disease 2019) pandemic. How this impacted adolescents' health, who were otherwise generally active in sports in their school, is examined in new research. What happened when adolescent athletes returned to organized sport in this pandemic?

Oncothyreon 2010 net loss decreases to 15.6 million

Oncothyreon Inc. today reported financial results for the year and quarter ending December 31, 2010.

EMA completes review of proposed amendment to OncoGenex's Phase 3 AFFINITY trial protocol

OncoGenex Pharmaceuticals, Inc. announced today that the European Medicines Agency has completed its review of the proposed amendment to the company's Phase 3 AFFINITY protocol and statistical analysis plan.

Read more Medical News

› Verified 8 days ago